{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/lung-pleural-cancers-recognition-referral/management/referral-for-suspected-lung-or-pleural-cancer/","result":{"pageContext":{"chapter":{"id":"9ac3a652-59bc-510c-968d-030e011cea68","slug":"referral-for-suspected-lung-or-pleural-cancer","fullItemName":"Scenario: Referral for suspected lung or pleural cancer","depth":2,"htmlHeader":"<!-- begin field 3550c40d-4955-49d1-bd96-8a1517ad6850 --><h2>Scenario: Referral for suspected lung or pleural cancer</h2><!-- end field 3550c40d-4955-49d1-bd96-8a1517ad6850 -->","summary":"Covers the referral of people with suspected lung or pleural cancer.","htmlStringContent":"<!-- begin item fef577f4-8f76-4c75-be6f-2ca793931586 --><!-- begin field 97b7548d-d7f4-48a2-bc0d-acd900ad6506 --><p>From birth onwards.</p><!-- end field 97b7548d-d7f4-48a2-bc0d-acd900ad6506 --><!-- end item fef577f4-8f76-4c75-be6f-2ca793931586 -->","topic":{"id":"7d8c9378-296e-5faf-9c97-f97a7697364d","topicId":"2a330e0f-ed6b-480c-bb50-2b5e80aec564","topicName":"Lung and pleural cancers - recognition and referral","slug":"lung-pleural-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"9ea3734a-4640-5249-855d-86a7092ebddf","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"df6756d2-9d89-5e47-9f87-390ace3c2f88","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"18a8d7b0-cc8b-52a5-bf11-5b539d78052d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ddf9ce79-381f-532e-a153-7a53082b9dfc","slug":"changes","fullItemName":"Changes"},{"id":"f3370663-425b-5c3e-a6fe-ad8d1be96f25","slug":"update","fullItemName":"Update"}]},{"id":"b640e31b-1f4c-503b-b1b1-91de8ec57b57","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6b427a6f-ecd1-57f9-bc9c-8212f64658ae","slug":"goals","fullItemName":"Goals"},{"id":"56d1fe21-599f-5036-9ae4-c194c8ecfcd1","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4f1882de-348a-5ffd-8787-7edd6086c3e1","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"906094b3-8374-5427-a7ca-e500758e8c36","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"917b5eb3-3056-5b9f-bc45-01e58d91a715","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0a9e6a42-74a9-55b7-a3a9-1f3a5af561e9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d8fdd748-ed5a-599c-ae21-563cf4a2aed9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3ce3c3b2-d4fb-5d6a-9802-34b237b7f8ff","slug":"presentation","fullItemName":"Presentation"},{"id":"f842e0db-8d8c-5498-b118-9eb5f444f84d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"62d79a78-e407-566b-8480-191e16e64a98","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"301f9cbc-ed6e-5b2c-ab2f-4b849ebd8fd9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"5ce929b0-6fa8-537c-a2bc-69d65d308bd4","slug":"symptoms-suggestive-of-lung-pleural-cancers","fullItemName":"Symptoms suggestive of lung and pleural cancers"}]},{"id":"221cc715-36b4-59c0-adf5-e58095958551","fullItemName":"Management","slug":"management","subChapters":[{"id":"9ac3a652-59bc-510c-968d-030e011cea68","slug":"referral-for-suspected-lung-or-pleural-cancer","fullItemName":"Scenario: Referral for suspected lung or pleural cancer"}]},{"id":"e1d33d1f-0766-5ee1-b233-210a781252ea","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"106b3c56-bc7c-5d9e-8469-217c3a2083aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bb1e2ffc-70c5-54eb-8afb-d1c5458cf19e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"58b0ff41-38be-59d9-87e1-00fdda60b74f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"76fd7f46-c7e3-5054-bac6-abe937c3262f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"596d16d1-c166-5b4d-b3eb-f325b5107e68","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4fa09ebf-46a1-57ac-9283-80299e9ebb7e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"dfb96fef-7e05-5329-800e-34ce172aab13","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"221cc715-36b4-59c0-adf5-e58095958551","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"2ede6091-d0c6-58a5-b58a-c18439923c70","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field d00e3598-144d-47a4-b6e2-b96c2b7db5cf --><h3>Referral timelines</h3><!-- end field d00e3598-144d-47a4-b6e2-b96c2b7db5cf -->","summary":null,"htmlStringContent":"<!-- begin item b05b0abf-cdc6-465f-8401-5ecd2fd1e15a --><!-- begin field 1b5a1b83-8acb-436e-964e-dedf532e5845 --><ul><li>The terms used in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> are as follows:<br><ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals.</li></ul></li></ul><!-- end field 1b5a1b83-8acb-436e-964e-dedf532e5845 --><!-- end item b05b0abf-cdc6-465f-8401-5ecd2fd1e15a -->","subChapters":[{"id":"23d0450f-0815-533a-8d71-281829b86184","slug":"basis-for-recommendation-0ae","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a698486e-6f73-4230-8343-bdb089c9cf0f --><h4>Basis for recommendation</h4><!-- end field a698486e-6f73-4230-8343-bdb089c9cf0f -->","summary":null,"htmlStringContent":"<!-- begin item 0ae40a45-73d3-4c00-a8d8-eff461b2d7aa --><!-- begin field 57643058-bfd9-4b82-aa6d-d6b794ce7e67 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 57643058-bfd9-4b82-aa6d-d6b794ce7e67 --><!-- end item 0ae40a45-73d3-4c00-a8d8-eff461b2d7aa -->","subChapters":[]}]},{"id":"0e0e70a5-2e3a-52d9-be04-75ffa5caf8a1","slug":"referral-for-suspected-lung-cancer","fullItemName":"Referral for suspected lung cancer","depth":3,"htmlHeader":"<!-- begin field 8b4b0b51-639c-466e-a22b-ed6b1520b1f3 --><h3>When should I refer a person with suspected lung cancer?</h3><!-- end field 8b4b0b51-639c-466e-a22b-ed6b1520b1f3 -->","summary":null,"htmlStringContent":"<!-- begin item 82cb5328-ffd8-46cd-ad45-70b5a34e2545 --><!-- begin field cb978e5d-78b6-4f8a-a7b8-1f29314390be --><ul><li><strong>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for lung cancer if they:</strong><ul><li>Have chest X-ray findings that suggest lung cancer, or</li><li>Are aged 40 years and over with unexplained haemoptysis.</li></ul></li><li><strong>Offer an urgent chest X-ray (to be performed within 2 weeks) to assess for lung cancer </strong>in people aged 40 years and over if they have two or more of the following unexplained symptoms, or if they have ever smoked and have one or more of the following unexplained symptoms:<ul><li>Cough.</li><li>Fatigue.</li><li>Shortness of breath.</li><li>Chest pain.</li><li>Weight loss.</li><li>Appetite loss.</li></ul></li><li><strong>Unexplained is defined as symptoms or signs that have not led to a diagnosis being made by the healthcare professional </strong><strong>in primary care after initial assessment </strong>(including history, examination, and any primary care investigations).</li><li><strong>Consider an urgent chest X-ray (to be performed within 2 weeks) to assess for lung cancer in people aged 40 years and over with any of the following:</strong><ul><li>Persistent or recurrent chest infection.</li><li>Finger clubbing.</li><li>Supraclavicular lymphadenopathy or persistent cervical lymphadenopathy.</li><li>Chest signs consistent with lung cancer.</li><li>Thrombocytosis.</li></ul></li></ul><!-- end field cb978e5d-78b6-4f8a-a7b8-1f29314390be --><!-- end item 82cb5328-ffd8-46cd-ad45-70b5a34e2545 -->","subChapters":[{"id":"c9ae4231-9bd6-5aa3-bcc6-bba89e6d68e6","slug":"basis-for-recommendation-58a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4e71788e-dcf0-4bcf-8494-c0267c0b9b94 --><h4>Basis for recommendation</h4><!-- end field 4e71788e-dcf0-4bcf-8494-c0267c0b9b94 -->","summary":null,"htmlStringContent":"<!-- begin item 58a742ed-93c4-4680-bd6f-5fc461240d15 --><!-- begin field 18cecc46-1283-4986-a0f8-aea31756c5b2 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 18cecc46-1283-4986-a0f8-aea31756c5b2 --><!-- end item 58a742ed-93c4-4680-bd6f-5fc461240d15 -->","subChapters":[]}]},{"id":"7710b66f-9c40-5a32-8433-76adc8014b32","slug":"referral-for-suspected-mesothelioma","fullItemName":"Referral for suspected mesothelioma","depth":3,"htmlHeader":"<!-- begin field 58cad132-e5a1-42c9-94ff-5d80fdbe1ec0 --><h3>When should I refer a person with suspected mesothelioma?</h3><!-- end field 58cad132-e5a1-42c9-94ff-5d80fdbe1ec0 -->","summary":null,"htmlStringContent":"<!-- begin item fd15bc11-90f8-45a9-939b-b7fc87f515b8 --><!-- begin field 3422e5d0-ae5b-4931-b486-ce2f85ba3058 --><ul><li><strong>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for mesothelioma if they have chest X-ray findings that suggest mesothelioma</strong>.</li><li><strong>Offer an urgent chest X-ray (to be performed within 2 weeks) to assess for mesothelioma </strong>in people aged 40 years and over, if they have:<ul><li>Two or more of the following unexplained symptoms, or</li><li>One or more of the following unexplained symptoms and have ever smoked, or</li><li>One or more of the following unexplained symptoms and have been exposed to asbestos:<ul><li>Cough.</li><li>Fatigue.</li><li>Shortness of breath.</li><li>Chest pain.</li><li>Weight loss.</li><li>Appetite loss.</li></ul></li></ul></li><li><strong>Consider an urgent chest X-ray (to be performed within 2 weeks) to assess for mesothelioma </strong>in people aged 40 years and over with either:<ul><li>Finger clubbing, or</li><li>Chest signs compatible with pleural disease.</li></ul></li></ul><!-- end field 3422e5d0-ae5b-4931-b486-ce2f85ba3058 --><!-- end item fd15bc11-90f8-45a9-939b-b7fc87f515b8 -->","subChapters":[{"id":"b7fb5955-a129-5128-9226-899442c2c237","slug":"basis-for-recommendation-824","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e98a15c7-c03a-4e5a-8141-fc155e669423 --><h4>Basis for recommendation</h4><!-- end field e98a15c7-c03a-4e5a-8141-fc155e669423 -->","summary":null,"htmlStringContent":"<!-- begin item 824c2c59-df5a-458f-a1c5-2c587c35432a --><!-- begin field 1b8b1d7d-111f-4e8e-9576-139f6dc0bea0 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 1b8b1d7d-111f-4e8e-9576-139f6dc0bea0 --><!-- end item 824c2c59-df5a-458f-a1c5-2c587c35432a -->","subChapters":[]}]},{"id":"334397f6-6b2c-528b-b3c0-900ef15ff2cb","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field 401d419d-a06b-4bb6-afbb-9a69492bd0b3 --><h3>Diagnostic and referral process</h3><!-- end field 401d419d-a06b-4bb6-afbb-9a69492bd0b3 -->","summary":null,"htmlStringContent":"<!-- begin item 039e6d69-8521-446e-881a-ead0df3db8c5 --><!-- begin field 1e18c134-ac56-4974-a1cc-b1def5cfcd77 --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field 1e18c134-ac56-4974-a1cc-b1def5cfcd77 --><!-- end item 039e6d69-8521-446e-881a-ead0df3db8c5 -->","subChapters":[{"id":"44c25eb3-9ca1-5d01-afd1-56395b61bfeb","slug":"basis-for-recommendation-6cd","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4b6774c8-cc61-41fd-83e7-6828d83557c4 --><h4>Basis for recommendation</h4><!-- end field 4b6774c8-cc61-41fd-83e7-6828d83557c4 -->","summary":null,"htmlStringContent":"<!-- begin item 6cdc8742-3a24-4913-8590-8efe73d03c13 --><!-- begin field 9472d743-2664-4a9c-9b24-06578d06f9dc --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 9472d743-2664-4a9c-9b24-06578d06f9dc --><!-- end item 6cdc8742-3a24-4913-8590-8efe73d03c13 -->","subChapters":[]}]},{"id":"8ddc3c78-8f56-5f24-8019-168afa0e7d33","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field 07ff05a6-dd5a-4b0b-aba8-8fbd779a395f --><h3>What patient information and support should I offer?</h3><!-- end field 07ff05a6-dd5a-4b0b-aba8-8fbd779a395f -->","summary":null,"htmlStringContent":"<!-- begin item 7afcf459-f30c-4865-8677-a1ac845f2e99 --><!-- begin field 39b7ba65-007c-435e-8cfa-2035b9ab2512 --><ul><li>Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field 39b7ba65-007c-435e-8cfa-2035b9ab2512 --><!-- end item 7afcf459-f30c-4865-8677-a1ac845f2e99 -->","subChapters":[{"id":"3b0e7a37-bd07-5b1a-b9a1-8916dd4f0861","slug":"basis-for-recommendation-019","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 51a4daa8-c2a8-4534-b3f7-9ab668fbc64d --><h4>Basis for recommendation</h4><!-- end field 51a4daa8-c2a8-4534-b3f7-9ab668fbc64d -->","summary":null,"htmlStringContent":"<!-- begin item 0194c77d-ba08-4cca-ae11-5304941f3f46 --><!-- begin field 3bbb3ed1-6909-4200-9834-749a98db4eac --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 3bbb3ed1-6909-4200-9834-749a98db4eac --><!-- end item 0194c77d-ba08-4cca-ae11-5304941f3f46 -->","subChapters":[]}]},{"id":"81a64f09-2a86-5129-b3ef-8abdd46befe3","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field d0176d69-4f89-48d3-8577-1dad175a9063 --><h3>Safety netting</h3><!-- end field d0176d69-4f89-48d3-8577-1dad175a9063 -->","summary":null,"htmlStringContent":"<!-- begin item 6564e12e-d583-4ca7-9059-11c21f80b3ba --><!-- begin field b5cf45c6-50f0-4f79-8f13-21d35c53422f --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field b5cf45c6-50f0-4f79-8f13-21d35c53422f --><!-- end item 6564e12e-d583-4ca7-9059-11c21f80b3ba -->","subChapters":[{"id":"a8e25344-ec9d-5984-bcf2-19485f8b46e7","slug":"basis-for-recommendation-e51","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 23d1f898-4eff-4af4-a7d6-06fbc4acb98d --><h4>Basis for recommendation</h4><!-- end field 23d1f898-4eff-4af4-a7d6-06fbc4acb98d -->","summary":null,"htmlStringContent":"<!-- begin item e515e69c-4ca2-4bcc-a221-7d5b3dce56aa --><!-- begin field e4a02d5f-5f84-4438-8950-627d7fd95b51 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lung-pleural-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field e4a02d5f-5f84-4438-8950-627d7fd95b51 --><!-- end item e515e69c-4ca2-4bcc-a221-7d5b3dce56aa -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}